No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2842331 |
chr14:69010690-69010691 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs17105821 |
chr14:69010731-69010732 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs566797667 |
chr14:69010787-69010788 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs534073667 |
chr14:69010799-69010800 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs11848742 |
chr14:69010868-69010869 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs573587306 |
chr14:69010878-69010879 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs2842330 |
chr14:69010925-69010926 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs544038519 |
chr14:69010943-69010944 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs11845733 |
chr14:69010959-69010960 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs574811032 |
chr14:69010973-69010974 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs17105822 |
chr14:69011043-69011044 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs563101547 |
chr14:69011059-69011060 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs528017909 |
chr14:69011071-69011072 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs373198558 |
chr14:69011094-69011095 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs182208721 |
chr14:69011147-69011148 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs376301385 |
chr14:69011171-69011172 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs148013587 |
chr14:69011195-69011196 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs17828907 |
chr14:69011205-69011206 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs17828913 |
chr14:69011294-69011295 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs529790766 |
chr14:69011331-69011332 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs548239429 |
chr14:69011482-69011483 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs566474754 |
chr14:69011547-69011548 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs540363869 |
chr14:69011554-69011555 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs561418376 |
chr14:69011574-69011575 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs140804980 |
chr14:69011664-69011665 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs572200261 |
chr14:69011703-69011704 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs375960324 |
chr14:69011790-69011791 |
Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs560094576 |
chr14:69011820-69011821 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs2525528 |
chr14:69011832-69011833 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs528605611 |
chr14:69011880-69011881 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs546991670 |
chr14:69011893-69011894 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs79114897 |
chr14:69011915-69011916 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs80089772 |
chr14:69011916-69011917 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs76826567 |
chr14:69011917-69011918 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs74546732 |
chr14:69011918-69011919 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs12435759 |
chr14:69011938-69011939 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs17755925 |
chr14:69011946-69011947 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs150143333 |
chr14:69011952-69011953 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs2158358 |
chr14:69011972-69011973 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
40 |
rs188192900 |
chr14:69012017-69012018 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs138870849 |
chr14:69012025-69012026 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs142892966 |
chr14:69012128-69012129 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs531881069 |
chr14:69012129-69012130 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs376518105 |
chr14:69012199-69012200 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs551300200 |
chr14:69012204-69012205 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs8017678 |
chr14:69012218-69012219 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs577182288 |
chr14:69012293-69012294 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs2525529 |
chr14:69012355-69012356 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs566534373 |
chr14:69012395-69012396 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs527301775 |
chr14:69012405-69012406 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|